Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-03-19

AUTHORS

Sudharsan Periyasamy-Thandavan, Suchreet Takhar, Adam Singer, Michael Robert Dohn, William Hutch Jackson, April Eve Welborn, Derek LeRoith, Mario Marrero, Muthusamy Thangaraju, Shuang Huang, Patricia Veronica Schoenlein

ABSTRACT

IntroductionIn this pre-clinical in vitro study conducted in estrogen receptor positive (ER+) breast cancer cells, we have characterized the effects of insulin-like growth factor I (IGF-1) on the cytostatic and cytotoxic action of antiestrogen treatment when used as a single agent or in combination with the antiprogestin mifepristone (MIF). Our goal was to identify new molecular targets to improve the efficacy of hormonal therapy in breast cancer patients that have a poor response to hormonal therapy, in part, due to high circulating levels of unbound insulinIGF-1.MethodsIGF-1-mediated effects on cytostasis and apoptotic cell death were determined with cell counts conducted in the presence and absence of trypan blue; enzyme-linked immunosorbent assays to determine the intracellular levels of cleaved cytokeratin 18, a marker of epithelial cancer cell apoptosis; and immunoblot analysis to determine the levels of cleaved poly-ADP ribose polymerase (PARP) and lamin A that result from caspase-dependent apoptosis. Cytotoxicity was further characterized by determination of the levels of reactive oxygen species (ROS) and the percent of mitochondrial membrane depolarization in cell populations treated with the different hormones in the presence and absence of IGF-1. Small molecule inhibitors of the dual-specificity protein kinase MEK1, MEK1 siRNA, Bim siRNA, and vectors overexpressing MEK1 wild type and mutant, dominant negative cDNA were used to identify key IGF-1 downstream prosurvival effectors.ResultsIGF-1, at physiologically relevant levels, blocked the cytotoxic action(s) of the antiestrogens 4-hydroxytamoxifen (4-OHT) and tamoxifen (TAM) when used as single agents or in combination with the antiprogestin MIF. The antiapoptotic action of IGF-1 was mediated primarily through the action of MEK1. MEK1 expression reduced the levels of ROS and mitochondrial membrane depolarization induced by the hormonal treatments via a mechanism that involved the phosphorylation and proteasomal turnover of the proapoptotic BH3-only Bcl-2 family member Bim. Importantly, small-molecule inhibitors of MEK1 circumvented the prosurvival action of IGF-1 by restoring Bim to levels that more effectively mediated apoptosis in ER+ breast cancer cells.Conclusionhis study provides strong support for the use of MEK1 inhibitors in combination with hormonal therapy to effectively affect cytostasis and activate a Bim-dependent apoptotic pathway in ER+ breast cancer cells. We discuss that MEK1 blockade may be a particularly effective treatment for women with high circulating levels of IGF-1, which have been correlated to a poor prognosis. More... »

PAGES

r52

References to SciGraph publications

  • 2005-09. Inhibition of Either Phosphatidylinositol 3-kinase/Akt or the Mitogen/Extracellular-regulated Kinase, MEK/ERK, Signaling Pathways Suppress Growth of Breast Cancer Cell Lines, but MEK/ERK Signaling is Critical for Cell Survival in BREAST CANCER RESEARCH AND TREATMENT
  • 1998-09. Additive effect of mifepristone and tamoxifen on apoptotic pathways in MCF-7 human breast cancer cells in BREAST CANCER RESEARCH AND TREATMENT
  • 2008-10-10. Tumour cell survival signalling by the ERK1/2 pathway in CELL DEATH & DIFFERENTIATION
  • 2011-03-07. Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer in ONCOGENE
  • 2001-11-15. Non-regulated and stimulated mechanisms cooperate in the nuclear accumulation of MEK1 in ONCOGENE
  • 2011-10-21. The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study in BREAST CANCER RESEARCH
  • 2002-08. A Novel High-Through-Put Assay for Screening of Pro-Apoptotic Drugs in INVESTIGATIONAL NEW DRUGS
  • 2009-09-01. Biological determinants of endocrine resistance in breast cancer in NATURE REVIEWS CANCER
  • 1998-05. Effect of antiprogestins and tamoxifen on growh inhibition of MCF-7 human breast cancer cells in nude mice in BREAST CANCER RESEARCH AND TREATMENT
  • 2002-06-05. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance in ONCOGENE
  • 2007. Estrogen Receptors in Resistance to Hormone Therapy in BREAST CANCER CHEMOSENSITIVITY
  • 2003-02-25. Enhancement of thymidine kinase-mediated killing of malignant glioma by BimS, a BH3-only cell death activator in GENE THERAPY
  • 2010-04-30. Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells in CELL DEATH & DIFFERENTIATION
  • 2009-09-29. Key signalling nodes in mammary gland development and cancer. Mitogen-activated protein kinase signalling in experimental models of breast cancer progression and in mammary gland development in BREAST CANCER RESEARCH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/bcr3153

    DOI

    http://dx.doi.org/10.1186/bcr3153

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1019064251

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/22429491


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Apoptosis Regulatory Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Bcl-2-Like Protein 11", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Breast Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Estrogen Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Estrogen Receptor Modulators", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hormone Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Insulin-Like Growth Factor I", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "MAP Kinase Kinase 1", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mifepristone", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Oxidative Stress", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphorylation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reactive Oxygen Species", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Estrogen", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tamoxifen", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Periyasamy-Thandavan", 
            "givenName": "Sudharsan", 
            "id": "sg:person.0774235463.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774235463.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Takhar", 
            "givenName": "Suchreet", 
            "id": "sg:person.016241417173.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016241417173.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Singer", 
            "givenName": "Adam", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA", 
              "id": "http://www.grid.ac/institutes/grid.152326.1", 
              "name": [
                "Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dohn", 
            "givenName": "Michael Robert", 
            "id": "sg:person.0700722655.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700722655.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jackson", 
            "givenName": "William Hutch", 
            "id": "sg:person.01337003046.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337003046.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Welborn", 
            "givenName": "April Eve", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA", 
              "id": "http://www.grid.ac/institutes/grid.59734.3c", 
              "name": [
                "Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "LeRoith", 
            "givenName": "Derek", 
            "id": "sg:person.0756555441.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756555441.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marrero", 
            "givenName": "Mario", 
            "id": "sg:person.0655015541.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655015541.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Biochemistry, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
                "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Thangaraju", 
            "givenName": "Muthusamy", 
            "id": "sg:person.013746210127.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013746210127.32"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Biochemistry, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
                "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Huang", 
            "givenName": "Shuang", 
            "id": "sg:person.0625462470.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625462470.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA", 
              "id": "http://www.grid.ac/institutes/grid.410427.4", 
              "name": [
                "Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA", 
                "Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Schoenlein", 
            "givenName": "Patricia Veronica", 
            "id": "sg:person.01004662215.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004662215.12"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1186/bcr2361", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040461259", 
              "https://doi.org/10.1186/bcr2361"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-0-387-74039-3_10", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042360122", 
              "https://doi.org/10.1007/978-0-387-74039-3_10"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/bcr3040", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044719011", 
              "https://doi.org/10.1186/bcr3040"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1006098910000", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035756397", 
              "https://doi.org/10.1023/a:1006098910000"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cdd.2010.41", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042843410", 
              "https://doi.org/10.1038/cdd.2010.41"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.gt.3301897", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001467529", 
              "https://doi.org/10.1038/sj.gt.3301897"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1016249728664", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042256597", 
              "https://doi.org/10.1023/a:1016249728664"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1205506", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011228248", 
              "https://doi.org/10.1038/sj.onc.1205506"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10549-005-4794-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035294705", 
              "https://doi.org/10.1007/s10549-005-4794-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc2713", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018166274", 
              "https://doi.org/10.1038/nrc2713"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/onc.2011.36", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011840580", 
              "https://doi.org/10.1038/onc.2011.36"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cdd.2008.148", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043432644", 
              "https://doi.org/10.1038/cdd.2008.148"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1204963", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018294528", 
              "https://doi.org/10.1038/sj.onc.1204963"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1006078032287", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047082193", 
              "https://doi.org/10.1023/a:1006078032287"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2012-03-19", 
        "datePublishedReg": "2012-03-19", 
        "description": "IntroductionIn this pre-clinical in vitro study conducted in estrogen receptor positive (ER+) breast cancer cells, we have characterized the effects of insulin-like growth factor I (IGF-1) on the cytostatic and cytotoxic action of antiestrogen treatment when used as a single agent or in combination with the antiprogestin mifepristone (MIF). Our goal was to identify new molecular targets to improve the efficacy of hormonal therapy in breast cancer patients that have a poor response to hormonal therapy, in part, due to high circulating levels of unbound insulinIGF-1.MethodsIGF-1-mediated effects on cytostasis and apoptotic cell death were determined with cell counts conducted in the presence and absence of trypan blue; enzyme-linked immunosorbent assays to determine the intracellular levels of cleaved cytokeratin 18, a marker of epithelial cancer cell apoptosis; and immunoblot analysis to determine the levels of cleaved poly-ADP ribose polymerase (PARP) and lamin A that result from caspase-dependent apoptosis. Cytotoxicity was further characterized by determination of the levels of reactive oxygen species (ROS) and the percent of mitochondrial membrane depolarization in cell populations treated with the different hormones in the presence and absence of IGF-1. Small molecule inhibitors of the dual-specificity protein kinase MEK1, MEK1 siRNA, Bim siRNA, and vectors overexpressing MEK1 wild type and mutant, dominant negative cDNA were used to identify key IGF-1 downstream prosurvival effectors.ResultsIGF-1, at physiologically relevant levels, blocked the cytotoxic action(s) of the antiestrogens 4-hydroxytamoxifen (4-OHT) and tamoxifen (TAM) when used as single agents or in combination with the antiprogestin MIF. The antiapoptotic action of IGF-1 was mediated primarily through the action of MEK1. MEK1 expression reduced the levels of ROS and mitochondrial membrane depolarization induced by the hormonal treatments via a mechanism that involved the phosphorylation and proteasomal turnover of the proapoptotic BH3-only Bcl-2 family member Bim. Importantly, small-molecule inhibitors of MEK1 circumvented the prosurvival action of IGF-1 by restoring Bim to levels that more effectively mediated apoptosis in ER+ breast cancer cells.Conclusionhis study provides strong support for the use of MEK1 inhibitors in combination with hormonal therapy to effectively affect cytostasis and activate a Bim-dependent apoptotic pathway in ER+ breast cancer cells. We discuss that MEK1 blockade may be a particularly effective treatment for women with high circulating levels of IGF-1, which have been correlated to a poor prognosis.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/bcr3153", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2472689", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2478808", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1022375", 
            "issn": [
              "1465-5411", 
              "1465-542X"
            ], 
            "name": "Breast Cancer Research", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "14"
          }
        ], 
        "keywords": [
          "mitochondrial membrane depolarization", 
          "reactive oxygen species", 
          "small molecule inhibitors", 
          "breast cancer cells", 
          "cancer cells", 
          "protein kinase MEK1", 
          "pro-apoptotic protein Bim", 
          "Bcl-2 family member Bim", 
          "caspase-dependent apoptosis", 
          "apoptotic cell death", 
          "hormonal therapy", 
          "IGF-1", 
          "MEK1 regulation", 
          "membrane depolarization", 
          "kinase MEK1", 
          "levels of ROS", 
          "proteasomal turnover", 
          "dominant-negative cDNA", 
          "ADP-ribose polymerase", 
          "cancer cell apoptosis", 
          "protein Bim", 
          "proapoptotic BH3", 
          "MEK1 inhibitor", 
          "antiprogestin mifepristone", 
          "wild type", 
          "new molecular targets", 
          "apoptotic pathway", 
          "MEK1 expression", 
          "cell death", 
          "prosurvival actions", 
          "single agent", 
          "molecule inhibitors", 
          "MEK1", 
          "ribose polymerase", 
          "estrogen receptor-positive breast cancer cells", 
          "insulin-like growth factor I", 
          "positive breast cancer cells", 
          "insulin-like growth factor-1", 
          "immunoblot analysis", 
          "cell apoptosis", 
          "factor 1", 
          "antiapoptotic action", 
          "breast cancer patients", 
          "intracellular levels", 
          "molecular targets", 
          "apoptosis", 
          "oxygen species", 
          "Bim siRNA", 
          "cell populations", 
          "growth factor I", 
          "growth factor-1", 
          "BH3", 
          "enzyme-linked immunosorbent", 
          "cytotoxic action", 
          "different hormones", 
          "ResultsIGF-1", 
          "poor prognosis", 
          "cells", 
          "antiestrogen treatment", 
          "cancer patients", 
          "poor response", 
          "siRNA", 
          "hormonal treatment", 
          "effective treatment", 
          "factor I", 
          "cell count", 
          "inhibitors", 
          "cytokeratin 18", 
          "mifepristone", 
          "trypan blue", 
          "therapy", 
          "cytostasis", 
          "relevant levels", 
          "mutants", 
          "cDNA", 
          "phosphorylation", 
          "polymerase", 
          "tamoxifen", 
          "antiestrogens", 
          "BIM", 
          "species", 
          "treatment", 
          "effectors", 
          "strong support", 
          "regulation", 
          "pathway", 
          "depolarization", 
          "expression", 
          "turnover", 
          "absence", 
          "levels", 
          "patients", 
          "prognosis", 
          "blockade", 
          "agents", 
          "immunosorbent", 
          "cytotoxic", 
          "target", 
          "hormone", 
          "action", 
          "markers", 
          "women", 
          "efficacy", 
          "death", 
          "mechanism", 
          "cytotoxicity", 
          "presence", 
          "population", 
          "study", 
          "count", 
          "vector", 
          "combination", 
          "percent", 
          "effect", 
          "response", 
          "analysis", 
          "types", 
          "use", 
          "blue", 
          "part", 
          "support", 
          "results", 
          "goal", 
          "determination"
        ], 
        "name": "Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim", 
        "pagination": "r52", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1019064251"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/bcr3153"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "22429491"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/bcr3153", 
          "https://app.dimensions.ai/details/publication/pub.1019064251"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:30", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_572.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/bcr3153"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/bcr3153'


     

    This table displays all metadata directly associated to this object as RDF triples.

    412 TRIPLES      21 PREDICATES      185 URIs      162 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/bcr3153 schema:about N0a87c8addae44daea0675983d0514cdc
    2 N0b0278b2bc8b4f5da95dc0406b6e6438
    3 N25c6ce248ac6445a831a6fb5eef873c4
    4 N36a086c3677d47a4965e9b152a96e758
    5 N4e80ed907bc94ec6b02123315e47cc5c
    6 N5a320148b5cf49e6911f52c5722240bf
    7 N5a4aa1c625c74daab867d612446fc466
    8 N5b8c7e7a7f0a41a2894a34da80a3f2d6
    9 N60585a59bec9418ab73aee4af501cd31
    10 N6903bfb9e5d34bd5918e64f96ba61ac5
    11 N69a9dcaca3dc4dabaf96f264aecff6cd
    12 N6c0a20bf745a4c0baffe4996f2f376af
    13 N755541aa79154944bc2b1259994f785a
    14 Nad6e43612d7545ab8fc0b1dd09433937
    15 Nb5dacc77addb4d16ba7232ae04341923
    16 Nc5545c1e629e413f9d942d12d2ce3068
    17 Nc82acbcb358e492f9dbd42b8b2842241
    18 Ndbc91ddc94d145ab9aaa84b6da780ede
    19 Nef8ab575d4674380a81486dddfe37cb1
    20 Nf1a12628674e49d488e33d2362f4c544
    21 Nfa3b404f95af405e8975134610118655
    22 anzsrc-for:11
    23 anzsrc-for:1103
    24 anzsrc-for:1112
    25 schema:author N62db72356ad64666983216023b2126e5
    26 schema:citation sg:pub.10.1007/978-0-387-74039-3_10
    27 sg:pub.10.1007/s10549-005-4794-6
    28 sg:pub.10.1023/a:1006078032287
    29 sg:pub.10.1023/a:1006098910000
    30 sg:pub.10.1023/a:1016249728664
    31 sg:pub.10.1038/cdd.2008.148
    32 sg:pub.10.1038/cdd.2010.41
    33 sg:pub.10.1038/nrc2713
    34 sg:pub.10.1038/onc.2011.36
    35 sg:pub.10.1038/sj.gt.3301897
    36 sg:pub.10.1038/sj.onc.1204963
    37 sg:pub.10.1038/sj.onc.1205506
    38 sg:pub.10.1186/bcr2361
    39 sg:pub.10.1186/bcr3040
    40 schema:datePublished 2012-03-19
    41 schema:datePublishedReg 2012-03-19
    42 schema:description IntroductionIn this pre-clinical in vitro study conducted in estrogen receptor positive (ER+) breast cancer cells, we have characterized the effects of insulin-like growth factor I (IGF-1) on the cytostatic and cytotoxic action of antiestrogen treatment when used as a single agent or in combination with the antiprogestin mifepristone (MIF). Our goal was to identify new molecular targets to improve the efficacy of hormonal therapy in breast cancer patients that have a poor response to hormonal therapy, in part, due to high circulating levels of unbound insulinIGF-1.MethodsIGF-1-mediated effects on cytostasis and apoptotic cell death were determined with cell counts conducted in the presence and absence of trypan blue; enzyme-linked immunosorbent assays to determine the intracellular levels of cleaved cytokeratin 18, a marker of epithelial cancer cell apoptosis; and immunoblot analysis to determine the levels of cleaved poly-ADP ribose polymerase (PARP) and lamin A that result from caspase-dependent apoptosis. Cytotoxicity was further characterized by determination of the levels of reactive oxygen species (ROS) and the percent of mitochondrial membrane depolarization in cell populations treated with the different hormones in the presence and absence of IGF-1. Small molecule inhibitors of the dual-specificity protein kinase MEK1, MEK1 siRNA, Bim siRNA, and vectors overexpressing MEK1 wild type and mutant, dominant negative cDNA were used to identify key IGF-1 downstream prosurvival effectors.ResultsIGF-1, at physiologically relevant levels, blocked the cytotoxic action(s) of the antiestrogens 4-hydroxytamoxifen (4-OHT) and tamoxifen (TAM) when used as single agents or in combination with the antiprogestin MIF. The antiapoptotic action of IGF-1 was mediated primarily through the action of MEK1. MEK1 expression reduced the levels of ROS and mitochondrial membrane depolarization induced by the hormonal treatments via a mechanism that involved the phosphorylation and proteasomal turnover of the proapoptotic BH3-only Bcl-2 family member Bim. Importantly, small-molecule inhibitors of MEK1 circumvented the prosurvival action of IGF-1 by restoring Bim to levels that more effectively mediated apoptosis in ER+ breast cancer cells.Conclusionhis study provides strong support for the use of MEK1 inhibitors in combination with hormonal therapy to effectively affect cytostasis and activate a Bim-dependent apoptotic pathway in ER+ breast cancer cells. We discuss that MEK1 blockade may be a particularly effective treatment for women with high circulating levels of IGF-1, which have been correlated to a poor prognosis.
    43 schema:genre article
    44 schema:isAccessibleForFree true
    45 schema:isPartOf N42b28e9e567d4085aac323d00c97e16a
    46 N612b97c5cf154b64a5882fdb10fc5399
    47 sg:journal.1022375
    48 schema:keywords ADP-ribose polymerase
    49 BH3
    50 BIM
    51 Bcl-2 family member Bim
    52 Bim siRNA
    53 IGF-1
    54 MEK1
    55 MEK1 expression
    56 MEK1 inhibitor
    57 MEK1 regulation
    58 ResultsIGF-1
    59 absence
    60 action
    61 agents
    62 analysis
    63 antiapoptotic action
    64 antiestrogen treatment
    65 antiestrogens
    66 antiprogestin mifepristone
    67 apoptosis
    68 apoptotic cell death
    69 apoptotic pathway
    70 blockade
    71 blue
    72 breast cancer cells
    73 breast cancer patients
    74 cDNA
    75 cancer cell apoptosis
    76 cancer cells
    77 cancer patients
    78 caspase-dependent apoptosis
    79 cell apoptosis
    80 cell count
    81 cell death
    82 cell populations
    83 cells
    84 combination
    85 count
    86 cytokeratin 18
    87 cytostasis
    88 cytotoxic
    89 cytotoxic action
    90 cytotoxicity
    91 death
    92 depolarization
    93 determination
    94 different hormones
    95 dominant-negative cDNA
    96 effect
    97 effective treatment
    98 effectors
    99 efficacy
    100 enzyme-linked immunosorbent
    101 estrogen receptor-positive breast cancer cells
    102 expression
    103 factor 1
    104 factor I
    105 goal
    106 growth factor I
    107 growth factor-1
    108 hormonal therapy
    109 hormonal treatment
    110 hormone
    111 immunoblot analysis
    112 immunosorbent
    113 inhibitors
    114 insulin-like growth factor I
    115 insulin-like growth factor-1
    116 intracellular levels
    117 kinase MEK1
    118 levels
    119 levels of ROS
    120 markers
    121 mechanism
    122 membrane depolarization
    123 mifepristone
    124 mitochondrial membrane depolarization
    125 molecular targets
    126 molecule inhibitors
    127 mutants
    128 new molecular targets
    129 oxygen species
    130 part
    131 pathway
    132 patients
    133 percent
    134 phosphorylation
    135 polymerase
    136 poor prognosis
    137 poor response
    138 population
    139 positive breast cancer cells
    140 presence
    141 pro-apoptotic protein Bim
    142 proapoptotic BH3
    143 prognosis
    144 prosurvival actions
    145 proteasomal turnover
    146 protein Bim
    147 protein kinase MEK1
    148 reactive oxygen species
    149 regulation
    150 relevant levels
    151 response
    152 results
    153 ribose polymerase
    154 siRNA
    155 single agent
    156 small molecule inhibitors
    157 species
    158 strong support
    159 study
    160 support
    161 tamoxifen
    162 target
    163 therapy
    164 treatment
    165 trypan blue
    166 turnover
    167 types
    168 use
    169 vector
    170 wild type
    171 women
    172 schema:name Insulin-like growth factor 1 attenuates antiestrogen- and antiprogestin-induced apoptosis in ER+ breast cancer cells by MEK1 regulation of the BH3-only pro-apoptotic protein Bim
    173 schema:pagination r52
    174 schema:productId N04a27c4fdef9467a825db97fd88be9f1
    175 N08a240fe368644f5b9c89d7b96b5be6e
    176 Nc1b4fd4fd00f4c5e822c28672c2cb000
    177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019064251
    178 https://doi.org/10.1186/bcr3153
    179 schema:sdDatePublished 2022-12-01T06:30
    180 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    181 schema:sdPublisher N27bd72e88e5c4e91903cc2c2aeeb00cd
    182 schema:url https://doi.org/10.1186/bcr3153
    183 sgo:license sg:explorer/license/
    184 sgo:sdDataset articles
    185 rdf:type schema:ScholarlyArticle
    186 N01e38cb681d14b7c8bd6f521127053c2 schema:affiliation grid-institutes:grid.410427.4
    187 schema:familyName Welborn
    188 schema:givenName April Eve
    189 rdf:type schema:Person
    190 N04a27c4fdef9467a825db97fd88be9f1 schema:name doi
    191 schema:value 10.1186/bcr3153
    192 rdf:type schema:PropertyValue
    193 N056b67927e8d4c9296c74cdafb28603d schema:affiliation grid-institutes:grid.410427.4
    194 schema:familyName Singer
    195 schema:givenName Adam
    196 rdf:type schema:Person
    197 N08a240fe368644f5b9c89d7b96b5be6e schema:name pubmed_id
    198 schema:value 22429491
    199 rdf:type schema:PropertyValue
    200 N0a87c8addae44daea0675983d0514cdc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Bcl-2-Like Protein 11
    202 rdf:type schema:DefinedTerm
    203 N0b0278b2bc8b4f5da95dc0406b6e6438 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Breast Neoplasms
    205 rdf:type schema:DefinedTerm
    206 N25c6ce248ac6445a831a6fb5eef873c4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Insulin-Like Growth Factor I
    208 rdf:type schema:DefinedTerm
    209 N27bd72e88e5c4e91903cc2c2aeeb00cd schema:name Springer Nature - SN SciGraph project
    210 rdf:type schema:Organization
    211 N2ccc32c6996849089abf50a94c04dfdc rdf:first N01e38cb681d14b7c8bd6f521127053c2
    212 rdf:rest Ne3bcad8d0f844f6786711fae6ecf84cf
    213 N3002c46f995b4c2d950f270bd1a95214 rdf:first sg:person.013746210127.32
    214 rdf:rest N47c907f06bd9492aaecfd6f4909ff177
    215 N36a086c3677d47a4965e9b152a96e758 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    216 schema:name Receptors, Estrogen
    217 rdf:type schema:DefinedTerm
    218 N42b28e9e567d4085aac323d00c97e16a schema:issueNumber 2
    219 rdf:type schema:PublicationIssue
    220 N47c907f06bd9492aaecfd6f4909ff177 rdf:first sg:person.0625462470.10
    221 rdf:rest N7e4e26d659cc410bb53c93f76114aed6
    222 N4d2b4f260ff4468aa6762797ec5d22a1 rdf:first sg:person.016241417173.08
    223 rdf:rest Nb08cfbd84fb04b67acf7e6c9ae57c9ca
    224 N4e80ed907bc94ec6b02123315e47cc5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    225 schema:name Reactive Oxygen Species
    226 rdf:type schema:DefinedTerm
    227 N5a320148b5cf49e6911f52c5722240bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    228 schema:name Estrogen Antagonists
    229 rdf:type schema:DefinedTerm
    230 N5a4aa1c625c74daab867d612446fc466 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    231 schema:name Estrogen Receptor Modulators
    232 rdf:type schema:DefinedTerm
    233 N5b8c7e7a7f0a41a2894a34da80a3f2d6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    234 schema:name Humans
    235 rdf:type schema:DefinedTerm
    236 N60585a59bec9418ab73aee4af501cd31 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    237 schema:name Apoptosis Regulatory Proteins
    238 rdf:type schema:DefinedTerm
    239 N612b97c5cf154b64a5882fdb10fc5399 schema:volumeNumber 14
    240 rdf:type schema:PublicationVolume
    241 N62db72356ad64666983216023b2126e5 rdf:first sg:person.0774235463.53
    242 rdf:rest N4d2b4f260ff4468aa6762797ec5d22a1
    243 N6903bfb9e5d34bd5918e64f96ba61ac5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    244 schema:name Tamoxifen
    245 rdf:type schema:DefinedTerm
    246 N69a9dcaca3dc4dabaf96f264aecff6cd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    247 schema:name Apoptosis
    248 rdf:type schema:DefinedTerm
    249 N6a3c79a26dc84f92b0e9d8deb641cef4 rdf:first sg:person.01337003046.60
    250 rdf:rest N2ccc32c6996849089abf50a94c04dfdc
    251 N6c0a20bf745a4c0baffe4996f2f376af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    252 schema:name Phosphorylation
    253 rdf:type schema:DefinedTerm
    254 N755541aa79154944bc2b1259994f785a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    255 schema:name Cell Line, Tumor
    256 rdf:type schema:DefinedTerm
    257 N7e4e26d659cc410bb53c93f76114aed6 rdf:first sg:person.01004662215.12
    258 rdf:rest rdf:nil
    259 Nad6e43612d7545ab8fc0b1dd09433937 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    260 schema:name Female
    261 rdf:type schema:DefinedTerm
    262 Nb08cfbd84fb04b67acf7e6c9ae57c9ca rdf:first N056b67927e8d4c9296c74cdafb28603d
    263 rdf:rest Nc9e992af203447babdc9072458a08325
    264 Nb5dacc77addb4d16ba7232ae04341923 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    265 schema:name Enzyme Inhibitors
    266 rdf:type schema:DefinedTerm
    267 Nc1b4fd4fd00f4c5e822c28672c2cb000 schema:name dimensions_id
    268 schema:value pub.1019064251
    269 rdf:type schema:PropertyValue
    270 Nc5545c1e629e413f9d942d12d2ce3068 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    271 schema:name Mifepristone
    272 rdf:type schema:DefinedTerm
    273 Nc82acbcb358e492f9dbd42b8b2842241 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    274 schema:name Hormone Antagonists
    275 rdf:type schema:DefinedTerm
    276 Nc9e992af203447babdc9072458a08325 rdf:first sg:person.0700722655.45
    277 rdf:rest N6a3c79a26dc84f92b0e9d8deb641cef4
    278 Nceb6edf13e3b4dd68d7b66650ace78b8 rdf:first sg:person.0655015541.06
    279 rdf:rest N3002c46f995b4c2d950f270bd1a95214
    280 Ndbc91ddc94d145ab9aaa84b6da780ede schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    281 schema:name Membrane Proteins
    282 rdf:type schema:DefinedTerm
    283 Ne3bcad8d0f844f6786711fae6ecf84cf rdf:first sg:person.0756555441.09
    284 rdf:rest Nceb6edf13e3b4dd68d7b66650ace78b8
    285 Nef8ab575d4674380a81486dddfe37cb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    286 schema:name Oxidative Stress
    287 rdf:type schema:DefinedTerm
    288 Nf1a12628674e49d488e33d2362f4c544 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    289 schema:name Proto-Oncogene Proteins
    290 rdf:type schema:DefinedTerm
    291 Nfa3b404f95af405e8975134610118655 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    292 schema:name MAP Kinase Kinase 1
    293 rdf:type schema:DefinedTerm
    294 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    295 schema:name Medical and Health Sciences
    296 rdf:type schema:DefinedTerm
    297 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    298 schema:name Clinical Sciences
    299 rdf:type schema:DefinedTerm
    300 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    301 schema:name Oncology and Carcinogenesis
    302 rdf:type schema:DefinedTerm
    303 sg:grant.2472689 http://pending.schema.org/fundedItem sg:pub.10.1186/bcr3153
    304 rdf:type schema:MonetaryGrant
    305 sg:grant.2478808 http://pending.schema.org/fundedItem sg:pub.10.1186/bcr3153
    306 rdf:type schema:MonetaryGrant
    307 sg:journal.1022375 schema:issn 1465-5411
    308 1465-542X
    309 schema:name Breast Cancer Research
    310 schema:publisher Springer Nature
    311 rdf:type schema:Periodical
    312 sg:person.01004662215.12 schema:affiliation grid-institutes:grid.410427.4
    313 schema:familyName Schoenlein
    314 schema:givenName Patricia Veronica
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004662215.12
    316 rdf:type schema:Person
    317 sg:person.01337003046.60 schema:affiliation grid-institutes:grid.410427.4
    318 schema:familyName Jackson
    319 schema:givenName William Hutch
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337003046.60
    321 rdf:type schema:Person
    322 sg:person.013746210127.32 schema:affiliation grid-institutes:grid.410427.4
    323 schema:familyName Thangaraju
    324 schema:givenName Muthusamy
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013746210127.32
    326 rdf:type schema:Person
    327 sg:person.016241417173.08 schema:affiliation grid-institutes:grid.410427.4
    328 schema:familyName Takhar
    329 schema:givenName Suchreet
    330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016241417173.08
    331 rdf:type schema:Person
    332 sg:person.0625462470.10 schema:affiliation grid-institutes:grid.410427.4
    333 schema:familyName Huang
    334 schema:givenName Shuang
    335 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0625462470.10
    336 rdf:type schema:Person
    337 sg:person.0655015541.06 schema:affiliation grid-institutes:grid.410427.4
    338 schema:familyName Marrero
    339 schema:givenName Mario
    340 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655015541.06
    341 rdf:type schema:Person
    342 sg:person.0700722655.45 schema:affiliation grid-institutes:grid.152326.1
    343 schema:familyName Dohn
    344 schema:givenName Michael Robert
    345 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700722655.45
    346 rdf:type schema:Person
    347 sg:person.0756555441.09 schema:affiliation grid-institutes:grid.59734.3c
    348 schema:familyName LeRoith
    349 schema:givenName Derek
    350 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0756555441.09
    351 rdf:type schema:Person
    352 sg:person.0774235463.53 schema:affiliation grid-institutes:grid.410427.4
    353 schema:familyName Periyasamy-Thandavan
    354 schema:givenName Sudharsan
    355 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0774235463.53
    356 rdf:type schema:Person
    357 sg:pub.10.1007/978-0-387-74039-3_10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042360122
    358 https://doi.org/10.1007/978-0-387-74039-3_10
    359 rdf:type schema:CreativeWork
    360 sg:pub.10.1007/s10549-005-4794-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035294705
    361 https://doi.org/10.1007/s10549-005-4794-6
    362 rdf:type schema:CreativeWork
    363 sg:pub.10.1023/a:1006078032287 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047082193
    364 https://doi.org/10.1023/a:1006078032287
    365 rdf:type schema:CreativeWork
    366 sg:pub.10.1023/a:1006098910000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035756397
    367 https://doi.org/10.1023/a:1006098910000
    368 rdf:type schema:CreativeWork
    369 sg:pub.10.1023/a:1016249728664 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042256597
    370 https://doi.org/10.1023/a:1016249728664
    371 rdf:type schema:CreativeWork
    372 sg:pub.10.1038/cdd.2008.148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043432644
    373 https://doi.org/10.1038/cdd.2008.148
    374 rdf:type schema:CreativeWork
    375 sg:pub.10.1038/cdd.2010.41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042843410
    376 https://doi.org/10.1038/cdd.2010.41
    377 rdf:type schema:CreativeWork
    378 sg:pub.10.1038/nrc2713 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018166274
    379 https://doi.org/10.1038/nrc2713
    380 rdf:type schema:CreativeWork
    381 sg:pub.10.1038/onc.2011.36 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011840580
    382 https://doi.org/10.1038/onc.2011.36
    383 rdf:type schema:CreativeWork
    384 sg:pub.10.1038/sj.gt.3301897 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001467529
    385 https://doi.org/10.1038/sj.gt.3301897
    386 rdf:type schema:CreativeWork
    387 sg:pub.10.1038/sj.onc.1204963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018294528
    388 https://doi.org/10.1038/sj.onc.1204963
    389 rdf:type schema:CreativeWork
    390 sg:pub.10.1038/sj.onc.1205506 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011228248
    391 https://doi.org/10.1038/sj.onc.1205506
    392 rdf:type schema:CreativeWork
    393 sg:pub.10.1186/bcr2361 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040461259
    394 https://doi.org/10.1186/bcr2361
    395 rdf:type schema:CreativeWork
    396 sg:pub.10.1186/bcr3040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044719011
    397 https://doi.org/10.1186/bcr3040
    398 rdf:type schema:CreativeWork
    399 grid-institutes:grid.152326.1 schema:alternateName Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA
    400 schema:name Department of Cancer Biology, Vanderbilt University, 2220 Pierce Ave., TN 37232, Nashville, USA
    401 rdf:type schema:Organization
    402 grid-institutes:grid.410427.4 schema:alternateName Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    403 Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    404 Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA
    405 schema:name Department of Biochemistry, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    406 Department of Cellular Biology and Anatomy, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    407 Institute of Vascular Biology, Georgia Health Sciences University, 1459 Laney Walker Blvd., 30912, Augusta, GA, USA
    408 Medical College of Georgia Cancer Center, Georgia Health Sciences University, 1410 Laney Walker Blvd., 30912, Augusta, GA, USA
    409 rdf:type schema:Organization
    410 grid-institutes:grid.59734.3c schema:alternateName Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA
    411 schema:name Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai School of Medicine, 1428 Madison Ave, 10029, New York, NY, USA
    412 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...